Castration-resistant prostate cancer

You have access
Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer
YANG YANG, XIN LI, KENZA MAMOUNI, OMER KUCUK and DAQING WU

Anticancer Research November 2017, 37 (11) 6235-6243;
You have access
Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer
HIROFUMI OBATA, MASAKI SHIOTA, NAOKO AKITAKE, ARIO TAKEUCHI, EIJI KASHIWAGI, TAKASHI DEJIMA, KEIJIRO KIYOSHIMA, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI and MASATOSHI ETO

Anticancer Research October 2017, 37 (10) 5631-5637;
You have access
Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel
JOST VON HARDENBERG, MAIKE SCHWARTZ, THORSTEN WERNER, STEFAN FUXIUS, MARKUS MÜLLER, THOMAS FRANGENHEIM, CHRISTIAN BOLENZ, CHRISTEL WEISS and ELMAR HEINRICH

Anticancer Research September 2017, 37 (9) 5117-5124;
You have access
Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer
HARUO KATO, YOSUKE FURUYA, YOSHIYUKI MIYAZAWA, TAKESHI MIYAO, TAKAHIRO SYUTO, MASASHI NOMURA, YOSHITAKA SEKINE, HIDEKAZU KOIKE, HIROSHI MATSUI, YASUHIRO SHIBATA, KAZUTO ITO and KAZUHIRO SUZUKI

Anticancer Research November 2016, 36 (11) 6141-6149;
You have access
Efficacy of Ethinylestradiol Re-challenge for Metastatic Castration-resistant Prostate Cancer
TAKEHISA ONISHI, TAKUJI SHIBAHARA, SATORU MASUI, YUSUKE SUGINO, SHINICHIRO HIGASHI and TAKESHI SASAKI

Anticancer Research June 2016, 36 (6) 2999-3004;
You have access
Prognosis of Castration-resistant Prostate Cancer Patients – Use of the AdnaTest® System for Detection of Circulating Tumor Cells
OTAKAR ČAPOUN, VERONIKA MIKULOVÁ, MARKÉTA JANČÍKOVÁ, HANA HONOVÁ, KATARÍNA KOLOŠTOVÁ, ROMAN SOBOTKA, PEŠL MICHAEL, TOMÁŠ ZIMA, TOMÁŠ HANUŠ and VIKTOR SOUKUP

Anticancer Research April 2016, 36 (4) 2019-2026;
You have access
Efficacy and Safety Profile of Enzalutamide for Japanese Patients with Castration-resistant Prostate Cancer
MUTSUSHI YAMASAKI, TAKESHI YUASA, SHINYA YAMAMOTO, TATSURO HAYASHI, MASAHIRO OGAWA, MIZUAKI SAKURA, HITOSHI MASUDA, IWAO FUKUI and JUNJI YONESE

Anticancer Research January 2016, 36 (1) 361-365;
You have access
Active Estrogen Synthesis and its Function in Prostate Cancer-derived Stromal Cells
KAZUAKI MACHIOKA, ATSUSHI MIZOKAMI, YURI YAMAGUCHI, KOUJI IZUMI, SHINICHI HAYASHI and MIKIO NAMIKI

Anticancer Research January 2015, 35 (1) 221-227;
You have access
Resistance to Abiraterone in Castration-resistant Prostate Cancer: A Review of the Literature
SILVANA GIACINTI, MARIA BASSANELLI, ANNA MARIA ASCHELTER, ANNALISA MILANO, MICHELA ROBERTO and PAOLO MARCHETTI

Anticancer Research November 2014, 34 (11) 6265-6269;
You have access
Circulating Tumor Cells as a Biomarker Predictive of Sensitivity to Docetaxel Chemotherapy in Patients with Castration-resistant Prostate Cancer
TAKATSUGU OKEGAWA, NAOSHI ITAYA, HIDEHIKO HARA, MITSUHIRO TAMBO and KIKUO NUTAHARA

Anticancer Research November 2014, 34 (11) 6705-6710;

Main menu

User menu

Search

Castration-resistant prostate cancer

Pages